Brand · Tablet · Updated Nov 11, 2026
Premarin 0.3 mg tablet price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for premarin 0.3 mg tablet and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Premarin 0.3 mg price history
What pharmacies pay for 30 tablets, weekly- Now
- $208.46
- 52-week low
- $202.83
- 52-week high
- $208.65
- A year ago
- $202.82
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Oct 21, 2026 | $6.95 | $6.95 | No change | pharmacies' invoice prices changed (survey) |
| Sep 23, 2026 | $6.95 | $6.95 | No change | pharmacies' invoice prices changed (survey) |
| Aug 19, 2026 | $6.95 | $6.95 | No change | pharmacies' invoice prices changed (survey) |
| Jul 22, 2026 | $6.95 | $6.95 | No change | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $6.95 | $6.95 | No change | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $6.94 | $6.95 | +0.2% | pharmacies' invoice prices changed (survey) |
| Jan 1, 2026 | $6.76 | $6.94 | +2.7% | WAC Adjustment |
| Dec 17, 2025 | $6.76 | $6.76 | No change | pharmacies' invoice prices changed (survey) |
Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for premarin 0.3 mg tablet
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
1 company sell premarin 0.3 mg tablet under 2 package codes (NDCs). Pharmacies pay the same per tablet whichever maker they buy from - the national average is set for the generic as a group.
| Maker | Package codes | Per unit |
|---|---|---|
| Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 0046-1100-81 0046-1100-91 | $6.95 |
All 2 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
The generic costs about the same
Questions to ask your pharmacist
- "Is the generic right for me?" The generic, estrogens, conjugated (usp) 0.3 mg tablet, costs pharmacies $158.91 for 30 tablets.
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other premarin strengths and forms
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 0.45 mg tablet Brand | $6.95 | $208.56 / 30 tablets |
| 0.625 mg tablet Brand | $6.94 | $208.17 / 30 tablets |
| 0.9 mg tablet Brand | $6.93 | $208.02 / 30 tablets |
| 1.25 mg tablet Brand | $6.95 | $208.44 / 30 tablets |
| 0.625 mg/mL vaginal cream Brand | $15.07 | $452.22 / 30 g |
Official label & what changed
These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942
WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER and PROBABLE DEMENTIA
WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER and PROBABLE DEMENTIA
See full prescribing information for complete boxed warning.
Estrogen-Alone Therapy
•
There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogens (5.2)
•
Estrogen-alone therapy should not be used for the prevention of cardiovascular disease or dementia (5.1, 5.3)
•
Women's Health Initiative (WHI) estrogen-alone substudy reported increased risks of stroke and deep vein thrombosis (DVT) (5.1)
•
The WHI Memory Study (WHIMS) estrogen-alone ancillary study of WHI reported an increased risk of probable dementia in postmenopausal women 65 years of age and older (5.3)
Estrogen Plus Progestin Therapy
•
Estrogen plus progestin therapy should not be used for the prevention of cardiovascular disease or dementia (5.1, 5.3)
•
The WHI estrogen plus progestin substudy reported increased risks of stroke, DVT, pulmonary embolism (PE), and myocardial infarction (MI) (5.1)
•
The WHI estrogen plus progestin substudy reported increased risks of invasive breast cancer (5.2)
•
The WHIMS estrogen plus progestin ancillary study of WHI reported an increased risk of probable dementia in postmenopausal women 65 years of age and older (5.3)
Estrogen-Alone Therapy
Endometrial Cancer
There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogens. Adding a progestin to estrogen therapy has been shown to reduce the risk of endometrial hyperplasia, which may be a precursor to endometrial cancer. Adequate diagnostic measures, including directed or random endometrial sampling when indicated, should be undertaken to rule out malignancy in postmenopausal women with undiagnosed persistent or recurring abnormal genital bleeding [see Warnings and Precautions (5.2)].
Cardiovascular Disorders and Probable Dementia
Estrogen-alone therapy should not be used for the prevention of cardiovascular disease or dementia [see Warnings and Precautions (5.1, 5.3), and Clinical Studies (14.5, 14.6)].
The Women's Health Initiative (WHI) estrogen-alone substudy reported increased risks of stroke and deep vein thrombosis (DVT) in postmenopausal women (50 to 79 years of age) during 7.1 years of treatment with daily oral conjugated estrogens (CE) (0.625 mg)-alone, relative to placebo [see Warnings and Precautions (5.1), and Clinical Studies (14.5)].
The WHI Memory Study (WHIMS) estrogen-alone ancillary study of WHI reported an increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 5.2 years of treatment with daily CE (0.625 mg)-alone, relative to placebo. It is unknown whether this finding applies to younger postmenopausal women [see Warnings and Precautions (5.3), Use in Specific Populations (8.5), and Clinical Studies (14.6)].
In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and other dosage forms of estrogens.
Estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.
Estrogen Plus Progestin Therapy
Cardiovascular Disorders and Probable Dementia
Estrogen plus progestin therapy should not be used for the prevention of cardiovascular disease or dementia [see Warnings and Precautions (5.1, 5.3), and Clinical Studies (14.5, 14.6)].
The WHI estrogen plus progestin substudy reported increased risks of DVT, pulmonary embolism (PE), stroke and myocardial infarction (MI) in postmenopausal women (50 to 79 years of age) during 5.6 years of treatment with daily oral CE (0.625 mg) combined with medroxyprogesterone acetate (MPA) [2.5 mg], relative to placebo [see Warnings and Precautions (5.1), and Clinical Studies (14.5)].
The WHIMS estrogen plus progestin ancillary study of the WHI, reported an increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 4 years of treatment with daily CE (0.625 mg) combined with MPA (2.5 mg), relative to placebo. It is unknown whether this finding applies to younger postmenopausal women [see Warnings and Precautions (5.3), Use in Specific Populations (8.5), and Clinical Studies (14.6)].
Breast Cancer
The WHI estrogen plus progestin substudy also demonstrated an increased risk of invasive breast cancer [see Warnings and Precautions (5.2), and Clinical Studies (14.5)].
In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and MPA, and other combinations and dosage forms of estrogens and progestins.
Estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about premarin 0.3 mg tablet
How much does premarin 0.3 mg tablet cost without insurance?
Pharmacies pay about $208.46 for 30 tablets ($6.95 per tablet) as of November 11, 2026. A fair cash price is about $250.23: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $249.73 including shipping.
Is my price for premarin 0.3 mg tablet fair?
Compare it with the fair cash price of $250.23 for 30 tablets. Up to about $312.79 is fair; above $500.46 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is premarin 0.3 mg tablet getting more expensive?
Over the last four weeks the price pharmacies pay held steady. Over a year it rose 2.8%. See the 52-week chart.
Is there a cheaper generic of Premarin 0.3 mg tablet?
Yes: estrogens, conjugated (usp) 0.3 mg tablet, which pharmacies get for $158.91 for the same amount.
Who makes premarin 0.3 mg tablet?
1 company: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. See every package code.
Is premarin in shortage?
No shortage is reported right now. We check every day.
Has premarin been recalled?
1 recall on record. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about premarin 0.3 mg tablet
No comments yet. Questions, tips, what worked for you - start the conversation.